Key Takeaways

  • Beware Hidden Markups: Some doctors may prescribe GLP-1 agonists like Ozempic at $1,500/month, while a compounded version from another clinic could cost as little as $300. This disparity often hides clinician profit, making your choice an ethical and financial one.
  • Dosing Can Be Dangerous: Even small doses can have extreme side effects. Dr. Abud Bakri experienced "projectile vomiting" and “the most miserable night of my life” after injecting just one milligram of Ozempic. Start slow, or risk severe acute illness.
  • Unknown Brain Effects: Modern GLP-1 drugs cause “thousandfold increases” in GLP-1 levels, far beyond older diabetes drugs. Andrew Huberman warns the long-term impact on neuroplasticity, learning, motivation, and the risk of anhedonia in younger users is largely unknown.
  • Continuous Use & Complications: These drugs often require ongoing use. Skipping meals or not consuming enough electrolytes while on high doses can lead to low blood pressure and general poor health, complicating your daily function.

The Unseen Price Tag of Weight Loss Drugs

In the ambitious world of startups and building, time is money, and efficiency is king. So-called miracle drugs for weight loss, like Ozempic, Mounjaro, and Retatrutide (GLP-1 agonists), promise a quick path to a leaner physique. But Andrew Huberman and Dr. Abud Bakri peel back the curtain on a hidden layer of cost that goes beyond your monthly prescription fee: potential conflicts of interest within the medical system.

Huberman recounts a scenario where a doctor prescribed him a GLP-1 drug for $1,500. He later learned, “the compounding pharmacy through a different doctor, a more benevolent doctor, Could have prescribed it to me for I could get for maybe $300. In the case where I'm paying 1,500, it's going to my physician unbeknownst to me.” This isn't just a cost discrepancy; it's a stark warning for founders who might unknowingly be lining a clinician's pockets, rather than getting the most cost-effective treatment. For founders managing tight budgets or seeking competitive advantages, understanding these financial dynamics is critical.

The Dark Side of Self-Experimentation

For those drawn to biohacking and pushing personal limits, GLP-1 agonists might seem like a new frontier. But the conversation between Huberman and Bakri delivers a sharp reality check on the dangers of improper dosing. These aren't supplements you can experiment with casually.

Dr. Bakri shared a harrowing personal experience: "I injected a I think it was a milligram of ombic. ... I go to do a shift. I was on a night shift that day and I've never had Charizard like projectile vomiting... it was the most miserable night of my life." This wasn't some uninformed user; this was an internal medicine physician. His takeaway: “so be very careful how you use these drugs. That's why titrate very slowly.” The temptation to fast-track results can lead to severe physical consequences, crippling your ability to work, think, or even function for days.

The Brain-Body Betrayal: Unknown Long-Term Effects

Beyond immediate side effects and ethical costs, there's a deeper, more troubling unknown for high-achievers considering GLP-1s: the long-term impact on your brain. Huberman points out that older diabetic drugs might increase GLP-1 levels by double or quadruple, but drugs like Mounjaro, Ozempic, and especially Retatrutide, cause “thousandfold increases in GPs.” He adds, “we don't know what the long-term effects of those are on like neuroplasticity and learning.”

For founders whose primary asset is their intellect, creativity, and drive, this is a serious red flag. Bakri also notes concerns about patients experiencing low blood pressure because they take mega-doses and “end up not eating like a day goes by, they've eaten one meal.” This kind of extreme caloric restriction, combined with drastically altered neurochemistry, raises questions about reduced motivation, anhedonia, and other cognitive shifts that could fundamentally alter your ability to operate at peak performance.

What to Do With This

Before you consider a GLP-1 agonist, demand transparency from your physician. Specifically ask about alternative sources, like compounded versions, and understand the cost differences. Inquire about any financial incentives for your doctor or clinic in prescribing a particular brand or source. If you do proceed, commit to a slow, careful titration protocol, even if it feels slow. Most importantly, pause and weigh the unknown long-term cognitive and psychological risks against the immediate benefits. Your brain is your most valuable asset; protect it from untested interventions.